New Artificial Intelligence Test for Leukemia Now Available in Europe

SOPHiA GENETICS has unveiled the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The standardized molecular diagnostic application represents a breakthrough in diagnostics for hematological diseases.